Annual Total Debt
$478.43 M
+$59.97 M+14.33%
December 31, 2023
Summary
- As of February 7, 2025, RVNC annual total debt is $478.43 million, with the most recent change of +$59.97 million (+14.33%) on December 31, 2023.
- During the last 3 years, RVNC annual total debt has risen by +$266.32 million (+125.56%).
- RVNC annual total debt is now at all-time high.
Performance
RVNC Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Debt
$483.45 M
-$8.19 M-1.67%
September 30, 2024
Summary
- As of February 7, 2025, RVNC quarterly total debt is $483.45 million, with the most recent change of -$8.19 million (-1.67%) on September 30, 2024.
- Over the past year, RVNC quarterly total debt has dropped by -$4.45 million (-0.91%).
- RVNC quarterly total debt is now -1.83% below its all-time high of $492.47 million, reached on March 31, 2022.
Performance
RVNC Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Debt Formula
Total Debt = Short Term Debt + Long Term Debt
RVNC Total Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +14.3% | -0.9% |
| 3 y3 years | +125.6% | +48.5% |
| 5 y5 years | +100.0% | +1506.4% |
RVNC Total Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +47.4% | -1.8% | +49.0% |
| 5 y | 5-year | at high | +1530.7% | -1.8% | +1547.7% |
| alltime | all time | at high | -100.0% | -1.8% | -100.0% |
Revance Therapeutics Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $483.45 M(-1.7%) |
| Jun 2024 | - | $491.64 M(+3.3%) |
| Mar 2024 | - | $475.78 M(-0.6%) |
| Dec 2023 | $478.43 M(+14.3%) | $478.43 M(-1.9%) |
| Sep 2023 | - | $487.90 M(+12.8%) |
| Jun 2023 | - | $432.39 M(-0.8%) |
| Mar 2023 | - | $435.72 M(+4.1%) |
| Dec 2022 | $418.47 M(+29.0%) | $418.47 M(-2.2%) |
| Sep 2022 | - | $427.91 M(-2.2%) |
| Jun 2022 | - | $437.69 M(-11.1%) |
| Mar 2022 | - | $492.47 M(+51.8%) |
| Dec 2021 | $324.51 M(+53.0%) | $324.51 M(-0.3%) |
| Sep 2021 | - | $325.61 M(-0.4%) |
| Jun 2021 | - | $326.93 M(+5.3%) |
| Mar 2021 | - | $310.37 M(+46.3%) |
| Dec 2020 | $212.11 M(+622.9%) | $212.11 M(+3.5%) |
| Sep 2020 | - | $204.87 M(+1.4%) |
| Jun 2020 | - | $201.96 M(+1.1%) |
| Mar 2020 | - | $199.82 M(+581.1%) |
| Dec 2019 | $29.34 M(>+9900.0%) | $29.34 M(-2.5%) |
| Sep 2019 | - | $30.09 M(-2.4%) |
| Jun 2019 | - | $30.83 M(-2.2%) |
| Mar 2019 | - | $31.53 M(>+9900.0%) |
| Dec 2018 | $0.00 | $0.00(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | $0.00(0.0%) |
| Jun 2018 | - | $0.00(-100.0%) |
| Mar 2018 | - | $983.00 K(-47.5%) |
| Dec 2017 | $1.87 M(-65.0%) | $1.87 M(-31.4%) |
| Sep 2017 | - | $2.73 M(-23.2%) |
| Jun 2017 | - | $3.55 M(-20.8%) |
| Mar 2017 | - | $4.49 M(-16.1%) |
| Dec 2016 | $5.35 M(-37.0%) | $5.35 M(-13.4%) |
| Sep 2016 | - | $6.17 M(-11.4%) |
| Jun 2016 | - | $6.97 M(-9.9%) |
| Mar 2016 | - | $7.74 M(-8.7%) |
| Dec 2015 | $8.48 M(+139.6%) | $8.48 M(-7.8%) |
| Sep 2015 | - | $9.19 M(-6.9%) |
| Jun 2015 | - | $9.88 M(+1087.4%) |
| Mar 2015 | - | $832.00 K(-76.5%) |
| Dec 2014 | $3.54 M(-86.1%) | $3.54 M(-63.5%) |
| Sep 2014 | - | $9.70 M(-17.4%) |
| Jun 2014 | - | $11.75 M(-14.9%) |
| Mar 2014 | - | $13.80 M(-45.8%) |
| Dec 2013 | $25.49 M(-76.1%) | $25.49 M(+94.9%) |
| Sep 2013 | - | $13.08 M(>+9900.0%) |
| Jun 2013 | - | $0.00(0.0%) |
| Mar 2013 | - | $0.00(-100.0%) |
| Dec 2012 | $106.45 M(+54.3%) | $106.45 M |
| Dec 2011 | $68.99 M | - |
FAQ
- What is Revance Therapeutics annual total debt?
- What is the all time high annual total debt for Revance Therapeutics?
- What is Revance Therapeutics annual total debt year-on-year change?
- What is Revance Therapeutics quarterly total debt?
- What is the all time high quarterly total debt for Revance Therapeutics?
- What is Revance Therapeutics quarterly total debt year-on-year change?
What is Revance Therapeutics annual total debt?
The current annual total debt of RVNC is $478.43 M
What is the all time high annual total debt for Revance Therapeutics?
Revance Therapeutics all-time high annual total debt is $478.43 M
What is Revance Therapeutics annual total debt year-on-year change?
Over the past year, RVNC annual total debt has changed by +$59.97 M (+14.33%)
What is Revance Therapeutics quarterly total debt?
The current quarterly total debt of RVNC is $483.45 M
What is the all time high quarterly total debt for Revance Therapeutics?
Revance Therapeutics all-time high quarterly total debt is $492.47 M
What is Revance Therapeutics quarterly total debt year-on-year change?
Over the past year, RVNC quarterly total debt has changed by -$4.45 M (-0.91%)